Implantable peptide-hydrogel drug delivery system for treating glioblastoma multiforme

摘要

Our results demonstrate that the efficacy of temozolomide was enhanced when delivered in a peptide hydrogel system. Further, the peptide hydrogel was able to efficiently load TMZ. Future studies will further evaluate the potential of the TMZ-loaded peptide hydrogel for treatment of GBM.